PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors

PDS Biotech Secures Initial PIPE Financing

PDS Biotech has closed the first tranche of a private placement financing, raising gross proceeds of $11.3 million as part of a round that could total up to $22.3 million.

PDS Biotech closes the first tranche of a PIPE financing led by Dr. Patrick Soon-Shiong, who joins the company's board as part of the deal.

The transaction was led by Dr. Patrick Soon-Shiong, the founder of NantWorks and a prominent figure in cancer immunotherapy and biotechnology investing, who is joining PDS Biotech's board of directors as part of the deal.

What a PIPE Financing Signals

Private investment in public equity, or PIPE, financings let public companies raise capital quickly from a small group of investors rather than through a broader public offering, a structure often used by smaller biotech firms that need funding to advance clinical programs without the time and cost of a traditional secondary offering.

Structuring the financing with an initial closing and the option for additional tranches up to $22.3 million gives the company flexibility to draw in more capital over time as milestones or investor commitments are finalized, rather than taking the full amount upfront.